Combating Multiple-Drug Resistance Polymicrobial Biofilm Infections with an Amphiphilic Cationic Photosensitizer

Area of Science:

• Photodynamic therapy
• Antimicrobial materials science
• Infectious disease research

Background:

• Polymicrobial infections and biofilms pose significant treatment challenges.
• Existing therapies are often ineffective against mixed bacterial populations and biofilms.
• Novel strategies are urgently needed to combat these threats.

Purpose of the Study:

• To design and evaluate amphiphilic cationic photosensitizers (PSs) for treating polymicrobial infections.
• To investigate the structure-activity relationships of different cationic side chains in PSs.
• To identify a potent PS capable of eradicating biofilms and promoting healing.

Main Methods:

• Synthesis of amphiphilic cationic PSs with varying side chains (pyridinium, imidazolium, etc.).
• Evaluation of photosensitizing properties, including reactive oxygen species generation (•OH, 1O2).
• Assessment of biofilm penetration and eradication capabilities against MRSA and MDR-PA.
• In vivo testing in a murine model with infected medical catheters.

Main Results:

• The pyridinium-modified PS, TBTCP-PY, showed superior performance.
• TBTCP-PY efficiently generated hydroxyl radicals and singlet oxygen upon light irradiation.
• It effectively penetrated extracellular polymeric substances (EPS) to eradicate MRSA-MDR-PA biofilms.
• In vivo studies demonstrated biofilm elimination, reduced inflammation, and enhanced wound healing.

Conclusions:

• TBTCP-PY is a promising candidate for treating complex polymicrobial biofilm infections.
• The study provides theoretical insights for developing novel antibiofilm materials.
• This approach offers a new avenue for combating antibiotic-resistant bacterial infections.